Strategic Development Partnership between Farfield Scientific and Monash University
Associate Professor Marie-Isabel Aguilar, leading the project at Monash, stated, "We propose to develop a new range of sensor chips with specifically designed and characterised phospholipid surfaces using patented Monash technology. We will analyse the structure of the different membrane surfaces using high-resolution and information-rich measurements from our Farfield AnaLight® Bio200 Dual Polarisation Interferometry instrument. We will then apply these sensor chips to the analysis of a range of peptide and protein membrane processes. The outcome will be a new-generation of biosensors that will provide unprecedented structural information that will underpin new developments in drug discovery and design. In particular, this technology may lead to the identification of new proteins and drug targets for therapeutic development. The long-term outcome would be the development of improved therapeutics which would be coupled to potential economic returns when further commercialisation is achieved."
Topics
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.